US health regulators withdraw rule change after 'significant adverse comment'

US health regulators tried to change the rules for how people can challenge agency decisions. They withdrew the change after receiving strong negative feedback. This means the old rules for regulatory hearings remain in place.

The US Food and Drug Administration (FDA) tried to streamline how it handles challenges to its decisions. This withdrawal shows that even small procedural changes can face strong resistance from affected parties. It suggests that any future attempts to alter these processes will likely face similar scrutiny.